16,723 research outputs found
Optical bright and dark states in side-coupled resonator structures
We analyze side-coupled standing-wave cavity structures consisting of Fabry-Perot and photonic crystal resonators coupled to two waveguides. We show that optical bright and dark states, analogous to those observed in coherent light-matter interactions, can exist in these systems. These structures may be useful for variable, switchable delay lines
Molecular characterisation of four double-flowered mutants of Silene dioica representing four centuries of variation
Records of double-flowered Silene dioica date from the late sixteenth century and four named varieties are grown today, as previously, for their horticultural interest. Although double-flowered mutants have been characterized in several plants, their study in dioecious species is of particular interest due to influences of the homeotic mutation on the different floral whorl configurations in males and females. We have analysed four double-flowered varieties of Silene dioica: Flore Pleno and Rosea Plena date back to the seventeenth and nineteenth centuries, Thelma Kay and Firefly were recognized in the latter part of the twentieth and early twenty-first centuries. We have analysed the floral structure of the four varieties, which have distinct floral architectures. Based on Y chromosome-specific PCR analysis we show that Firefly is male and that the other three varieties are female: Random Amplification of Polymorphic DNA (RAPD) analyses suggested a common origin for the three female varieties. The double-flowered phenotype in all four varieties is caused by mutation of the C-function MADS-box transcription factor gene SDM1. We show that Firefly carries a unique 44bp insertion into SDM1, revealing an independent origin for this variety. Comparative analysis of SDM1 cDNA and genomic sequences in Flore Pleno, Rosea Plena and Thelma Kay shows that all three are caused by the same 7bp insertion within SDM1 and therefore share a common origin. The three alleles also differ by several single nucleotide polymorphisms, which represent somatic mutations accumulated over four centuries of asexual propagation
Discovering Class-Specific Pixels for Weakly-Supervised Semantic Segmentation
We propose an approach to discover class-specific pixels for the
weakly-supervised semantic segmentation task. We show that properly combining
saliency and attention maps allows us to obtain reliable cues capable of
significantly boosting the performance. First, we propose a simple yet powerful
hierarchical approach to discover the class-agnostic salient regions, obtained
using a salient object detector, which otherwise would be ignored. Second, we
use fully convolutional attention maps to reliably localize the class-specific
regions in a given image. We combine these two cues to discover class-specific
pixels which are then used as an approximate ground truth for training a CNN.
While solving the weakly supervised semantic segmentation task, we ensure that
the image-level classification task is also solved in order to enforce the CNN
to assign at least one pixel to each object present in the image.
Experimentally, on the PASCAL VOC12 val and test sets, we obtain the mIoU of
60.8% and 61.9%, achieving the performance gains of 5.1% and 5.2% compared to
the published state-of-the-art results. The code is made publicly available
Recommended from our members
Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.
With recent advances in our understanding of the continuous pathophysiological changes that begin many years prior to symptom onset, it is now apparent that Alzheimer's disease cannot be adequately described by discrete clinical stages, but should also incorporate the continuum of biological changes that precede and underlie the clinical representation of the disease. By jointly considering longitudinal changes of all available biomarkers and clinical assessments, variation within individuals can be integrated into a single continuous measure of disease progression and used to identify the earliest pathophysiological changes. Disease time, a measure of disease severity, was estimated using a Bayesian latent time joint mixed-effects model applied to an array of imaging, biomarker and neuropsychological data. Trajectories of regional amyloid β and tau PET uptake were estimated as a function of disease time. Regions with early signs of elevated amyloid β uptake were used to form an early, focal composite and compared to a commonly used global composite, in a separate validation sample. Disease time was estimated in 279 participants (183 cognitively unimpaired individuals, 61 mild cognitive impairment and 35 Alzheimer's disease dementia patients) with available amyloid β and tau PET data. Amyloid β PET uptake levels in the posterior cingulate and precuneus start high and immediately increase with small increases of disease time. Early elevation in tau PET uptake was found in the inferior temporal lobe, amygdala, banks of the superior temporal sulcus, entorhinal cortex, middle temporal lobe, inferior parietal lobe and the fusiform gyrus. In a separate validation sample of 188 cognitively unimpaired individuals, the early, focal amyloid β PET composite showed a 120% increase in the accumulation rate of amyloid β compared to the global composite (P < 0.001), resulting in a 60% increase in the power to detect a treatment effect in a primary prevention trial design. Ordering participants on a continuous disease time scale facilitates the inspection of the earliest signs of amyloid β and tau pathology. To detect early changes in amyloid β pathology, focusing on the earliest sites of amyloid β accumulation results in more powerful and efficient study designs in early Alzheimer's disease. Targeted composites could be used to re-examine the thresholds for amyloid β-related study inclusion, especially as the field shifts to focus on primary and secondary prevention. Clinical trials of anti-amyloid β treatments may benefit from the use of focal composites when estimating drug effects on amyloid β and tau changes in populations with minimal amyloid β and tau pathology and limited expected short-term accumulation
- …